Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- EU Panel Gives Thumbs-Up to Avastin Biosimilar
July 28, 2020
- Daiichi Sankyo, AstraZeneca to Collaborate for Another ADC
July 28, 2020
- Lyrica Expected to Face Generic Onslaught by Year’s End as Patent Ruled Invalid
July 28, 2020
- EU Panel Backs Kyowa Kirin’s Crysvita for Adult XLH
July 28, 2020
- StemRIM Bags 1.7 Billion Yen from Shionogi for Expanded Deal on Regeneration-Inducing Medicine
July 28, 2020
- Chugai, Biofourmis to Develop Digital Solution to Objectively Assess Endometriosis Pain
July 27, 2020
- Astellas Earns NIH Grant for Potential Opioid Use Disorder Med
July 27, 2020
- Dosing of Low-Dose COVID-19 Vaccine Completed: AnGes PI/II Study
July 27, 2020
- Daiichi Sankyo Inks ADC Pact with Gustave Roussy
July 27, 2020
- Nihon Chouzai Launches Drug Information Service with Standard Formulary Including Few New Meds
July 27, 2020
- Chiome to Launch First-in-Human Trial for Anti-DLK-1 Antibody
July 22, 2020
- Shonan iPark’s VC Consortium Now Up and Running
July 22, 2020
- 9-Valent HPV Vaccine Hits Finish Line, but Japan Launch Schedule Uncertain with High Global Demand
July 22, 2020
- Mochida, Shimane Univ. Start Collaborative Research on New Treatment for Joint Disease
July 22, 2020
- Daiichi Sankyo’s Prasugrel Hits Primary Goal in Japan PIII for Thrombotic Stroke, Filing for Label Expansion Planned in 2021
July 22, 2020
- MSD Launches Injectable Version of Deep Mycosis Drug Noxafil
July 22, 2020
- Japan Approves MSD’s 9-Valent HPV Vaccine 5 Years after Filing
July 21, 2020
- AstraZeneca Aims to Deliver100 Million Doses of Coronavirus Vaccine to Japan: CEO
July 21, 2020
- National CV Center Spin-Off Developing Oligonucleotide Therapy for Dyslipidemia, Eyes 1st Trial in FY2022
July 20, 2020
- Mitsubishi Tanabe Earns Indonesian OK for ALS Med
July 17, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…